CLASS 1 RECALL - TARGOCID 200MG POWDER FOR SOLUTION FOR INJECTION/INFUSION OR ORAL SOLUTION

Sanofi UK is initiating an urgent recall of the above batches of Targocid 200mg powder for solution for injection/infusion or oral solution.

This is due to out of specification results obtained for bacterial endotoxins, which has been confirmed through testing of retain samples. This issue was observed following a medical adverse event, which reported that four patients experienced high grade of fever approximately three hours post-administration of vials from the impacted batches.

Due to the out of specification results observed there is a potential life threatening or serious risk to patient health.

MHRA drug alert date: 21st October 2022

MHRA drug alert link: 

https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-targocid-200mg-powder-for-solution-for-injection-slash-infusion-or-oral-solution-aventis-pharma-limited-t-slash-a-sanofi-due-to-the-presence-of-bacteria?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=e7cf2b1f-d939-4835-991d-d771d9d5fe1b&utm_content=immediately

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

Further information

For more information on licensed stock and resupply queries for the licensed presentation, please contact GB-CustomerServices@sanofi.com; phone number: 0800 854 430.

For medical information queries and all other enquiries, please contact uk-medicalinformation@sanofi.com; phone number: 0800 035 25 25.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

CLASS 2 RECALL - EPHEDRINE HYDROCHLORIDE 30MG/ML SOLUTION FOR INJECTION

hameln pharma ltd is initiating a recall of the affected batches of Ephedrine Hydrochloride 30 mg/ml Solution for Injection as a precautionary measure.

MHRA drug alert date: 20 October 2022

MHRA drug alert link:  https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-ephedrine-hydrochloride-30-mg-slash-ml-solution-for-injection-el-22-a-slash-44?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=4eaf7378-a167-4795-8f45-fc22c803cc75&utm_content=immediately

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

For more information or supply queries, please contact or email hameln pharma ltd customer services on +44 (0)1452 621 661 or customer.services@hameln-pharma.co.uk

For medical information queries, please contact or email hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or drug.safety@hameln-pharma.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Alliance Healthcare Raises £20,000 To Create Healthier Futures

Alliance Healthcare teams come together to raise vital funds to fight cancer and support the health and wellbeing of children.

Alliance Healthcare hosted its annual North and South Championship events in October where colleagues competed in various football and netball tournaments to raise more than £20,000 for Action Medical Research, Vitamin Angels UK, EORTC and the Theodora Children’s Charity.

Lucy Holloway, Corporate Events Fundraiser at Action Medical Research said: “We are really grateful for events like the annual Alliance Healthcare Championships. Our charity could not fund the medical research needed to benefit young children and babies without the support of dedicated teams at Alliance Healthcare. Thank you!”

These events not only raise a large amount of funds that will help the fight against cancer and improve children’s lives in the UK and across the world, but they also bring together colleagues, families, friends, and communities, with one united purpose, to create healthier futures.

Ennogen, a loyal sponsor of the event once again entered a team and Alex Durall, Head of UK Sales and Customer Relations Manager, Ennogen said: “We are always really keen to sponsor this event as it’s always a great family fun day out, whilst coming together for four worthy causes.”

Now in its 9th year, Alliance Healthcare has raised over £150,000 from its flagship fundraising event since its origin in 2013. This year’s netball winners were Team Ennogen, beating the Support Centre Team in the final 13-8. In the football, it was Leigh Service Centre that triumphed in the north event, and therefore qualified for the south event where they finally took home the Champions title.

Pablo Rivas, Chief Operating Office, Alliance Healthcare presented the winning teams with trophies and champagne, plus a £100 voucher for the teams to celebrate in style and said: “The Championship events are a great example of bringing our colleagues together to give back to their communities. We are committed to our purpose, our fight against cancer and the wellbeing of children.”

Alliance Healthcare and its chosen charities send their most sincere thanks to all of this year’s sponsors: Crescent Pharma, Ennogen, Relonchem, Iafeya, Tillomed, Viatris, HDA, Essity, MacLeod’s Pharma and Brown & Burk.

Celebrating Pharmacy Innovation at the House of Commons

Alliance Healthcare celebrated the very best in pharmacy at the House of Lords as sponsors of the Innovation Awards at the Independent Pharmacy Awards.

Raj Nutan, Healthcare Strategy and Services Director, Alliance Healthcare and Sam Unsworth, Head of Communications, Alliance Healthcare had the honour to represent Alliance Healthcare at the prestigious setting, where Sam presented the award and said: “Innovation is essential to deliver the best service to patients. That’s why Alliance Healthcare is delighted to sponsor the Innovation Award at the Independent Pharmacy Awards.”

Deborah Evans, Remedi Health, Hampshire was our winner, who wowed the judges with her ability to not only lead but think outside the box.

Deborah has worked in pharmacy for over 35 years and runs a GpHC-registered private pharmacy which only opened last year. She has pulled together a brilliant team of 12 who have rolled out a range of private services for their patients – and in deciding not to provide NHS services, she has made a real success of her business in very tough times.

Her business model reverses the traditional community pharmacy approach. Instead of her predominately prescription and medicines business that offers services, hers is predominately a clinical service business of which medicines and prescriptions are part of the solution for the clients. The judges described Deborah as “an inspiration.”

Find out more about the awards here.

Company Led Recall - Endwarts freeze 7.5g

Viatris have informed that product Endwarts Freeze^® has been manufactured with 5 tips instead of the stipulated 7 as indicated on the packaging and leaflet.

MHRA drug alert link: N/A   

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

For more information please contact VIATRIS UK HEALTHCARE

Gary Marshall Gary.marshall@viatris.com 07817 486960

Class 4 Medicines Defect Information: Flamingo Pharma UK Ltd, Ibuprofen 400mg Tablets, Paracetamol 500mg Tablets (Caplets)

Flamingo Pharma UK Ltd has identified an error relating to the ink printing of the batch number and expiry date on the carton for three batches of Ibuprofen 400mg Tablets. This notification includes all potentially impacted products/batches.

MHRA drug alert date:  12th October 2022

MHRA drug alert link: 

https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-flamingo-pharma-uk-ltd-ibuprofen-400mg-tablets-paracetamol-500mg-tablets-caplets-el-22-a-slash-43?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ffbd7a57-60fc-4de6-afd0-d1d3fb960b3e&utm_content=immediately#download-document

This is a caution in use only we are not accepting stock returns - if any defective stock is found it should be returned directly to the manufacturer.

Further Information

For medical information and stock control queries please contact:

Flamingo Pharma

For medical information safety@flamingopharma.co.uk or general product enquiry sales@flamingopharma.co.uk +44 (0) 7733522465

Or

Mawdsley Brooks & Co Ltd

Overlabellingcustomerservices@mawdsleys.co.uk 01302 553064

Recipients of this Medicines Notification should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.

CLASS 2 RECALL - AMIODARONE HYDROCHLORIDE 50MG/ML SOLUTION FOR INJECTION/INFUSION

hameln pharma ltd is initiating a recall of batch 210505 of Amiodarone Hydrochloride 50 mg/ml Concentrate for Solution for Injection/Infusion as a precautionary measure. This is due to an increased presence of visible crystalline particles within the solution, identified during ongoing re-inspection of retained samples.

MHRA drug alert date: 11 October 2022

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-hameln-pharma-ltd-amiodarone-hydrochloride-50-mg-slash-ml-concentrate-for-solution-for-injection-slash-infusion-el-22-a-slash-42?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=8736ec08-585b-4e2f-9985-026dc8594eef&utm_content=immediately

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

For more information or supply queries, please contact or email hameln pharma ltd customer services on +44 (0)1452 621 661 or customer.services@hameln-pharma.co.uk

For medical information queries, please contact or email hameln pharma ltd Medicines Information on +44 (0)1452 621 661 or drug.safety@hameln-pharma.co.uk

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

CLASS 2 RECALL - STEMETIL 5MG/5ML SYRUP

Sanofi is recalling all batches of the above product as a precautionary measure due to the identification of N-nitrosomethylphenylamine (NMPA) above the acceptable limit. Nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time.

MHRA drug alert date: 10 October 2022

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-aventis-pharma-limited-t-slash-a-sanofi-stemetil-5mg-slash-5ml-syrup-el-22-a-slash-41?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=8744b402-2664-40d4-a81b-0fbedeefc431&utm_content=immediately

Alliance do not stock the above products so we will not be accepting Customer returns on this recall.

For stock control enquiries please contact:

GB-CustomerServices@sanofi.com

Phone number: 0800 854 430

For more information or medical information please contact:

uk-medicalinformation@sanofi.com

Phone number: 0800 035 25 25.

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Janssen Neuroscience RWA

We are pleased to announce that, as of 01 November 2022, Alliance Healthcare will become the only wholesaler to supply selected products from Janssen’s neuroscience product portfolio to all pharmacies, hospitals, and dispensing doctors in Great Britain. Supply to Northern Ireland is not included in this agreement.

A full list of the selected products is available here.

Some service disruption - 29 September 2022

Due to a network issue overnight which has since been fully resolved, there may be some disruption to service across our network (except Northern Ireland). Impacted customers are being contacted. We are sorry for any inconvenience caused.

Please contact Customer Service with any emergency requirements.